BlackRock Health Sciences Trust (NYSE:BME) to Issue Monthly Dividend of $0.26

BlackRock Health Sciences Trust (NYSE:BME) announced a monthly dividend on Friday, June 5th. Investors of record on Wednesday, July 15th will be given a dividend of 0.2621 per share on Friday, July 31st. This represents a c) dividend on an annualized basis and a yield of 7.3%. The ex-dividend date of this dividend is Wednesday, July 15th.

BlackRock Health Sciences Trust Stock Performance

Shares of BME opened at $43.03 on Monday. BlackRock Health Sciences Trust has a twelve month low of $35.03 and a twelve month high of $44.35. The company has a 50 day moving average of $40.54 and a two-hundred day moving average of $40.71.

Institutional Trading of BlackRock Health Sciences Trust

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Sound Income Strategies LLC purchased a new position in BlackRock Health Sciences Trust during the 1st quarter worth $36,000. Northwestern Mutual Wealth Management Co. raised its stake in BlackRock Health Sciences Trust by 22.2% in the third quarter. Northwestern Mutual Wealth Management Co. now owns 1,417 shares of the company’s stock valued at $53,000 after buying an additional 257 shares during the last quarter. Geneos Wealth Management Inc. raised its stake in BlackRock Health Sciences Trust by 200.0% in the second quarter. Geneos Wealth Management Inc. now owns 4,899 shares of the company’s stock valued at $179,000 after buying an additional 3,266 shares during the last quarter. Fifth Third Bancorp acquired a new stake in BlackRock Health Sciences Trust in the first quarter worth about $180,000. Finally, Money Concepts Capital Corp acquired a new stake in BlackRock Health Sciences Trust in the first quarter worth about $209,000.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.